Investing Profile

Robert Weisskoff

InvestorVC
Partner at F-Prime Capital
Photo of Robert Weisskoff, Partner at F-Prime Capital Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Moving Capital Network
963 CONNECTIONS
Moving Capital Network
963 CONNECTIONS
Moving Capital Network
963 CONNECTIONS
Harvard University Network
772 CONNECTIONS
Massachusetts Institute of Technology Network
521 CONNECTIONS
cb
$100K - $10.0M
$5.0M
9
CompanyStageDateRound SizeTotal Raised
Countable Labs
Series AMay 2026$26M
$26M
Co-investors: Corey Ritter (ARCH Venture Partners)
Affinia Therapeutics
Series COct 2025$40M
Series BMay 2021$110M
Series AMar 2020$60M
$210M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), David Grayzel (Atlas Venture)
Shinobi Therapeutics
Series ADec 2023$51M
$51M
Co-investors: Fouad Azzam (EQT Life Sciences)
RareCyte
Series GSep 2021$24M
$76M
Co-investors: Brian Daniels (5am Ventures), Robert Shepler (Telegraph Hill Partners), David Kabakoff (HealthQuest Capital), Jan Garfinkle (Arboretum Ventures)
Adela
Series AJun 2021$60M
$60M
Tempest Therapeutics
Series BMar 2018$70M
$85M
Co-investors: Tom Woiwode (Versant Ventures)
PlasmaGen Biosciences
Series UnknownAug 2017$25M
$25M
Sr. Physicist Advanced NMR SystemsPresent
Sr. Physicist Moving CapitalPresent
Associate Professor of Radiology Harvard Medical SchoolPresent
Director, MR Imaging Core Massachusetts General HospitalPresent
VP Business Development EPIX PharmaceuticalsPresent
VP Business Development Moving CapitalPresent
Partner F-Prime CapitalPresent
Partner Moving CapitalPresent
Harvard University AB Physics
Massachusetts Institute of Technology PhD Physics
Sign in with Google →
Sign in with Google →